Psychemedics Corporation Reports 2023 Financial Results
March 28, 2024 08:20 ET
|
Psychemedics Corporation
DALLAS, March 28, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, announced today financial results for the year...
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
March 21, 2024 09:00 ET
|
Psychemedics Corporation
Psychemedics Corporation announces its recognition as one of the Top 10 Employee Health Testing Services Providers for 2024 by ManageHR
Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
January 02, 2024 11:27 ET
|
Psychemedics Corporation
Psychemedics Corporation, a global leader in hair testing for drugs of abuse, announces the relocation of its corporate headquarters.
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
November 27, 2023 09:00 ET
|
Psychemedics Corporation
ACTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for substance abuse, proudly announces the appointment of Daniella Mehalik as...
Psychemedics Corporation Reports Third Quarter 2023 Financial Results
November 09, 2023 17:00 ET
|
Psychemedics Corporation
ACTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a leading provider of hair testing for drugs of abuse, today announced financial results for the third quarter...
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
October 27, 2023 11:00 ET
|
Psychemedics Corporation
Psychemedics debuts a 5-panel drug test replacing marijuana with fentanyl, the first hair drug test exclusively targeting the most dire workplace threats.
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
September 21, 2023 17:00 ET
|
Psychemedics Corporation
ACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s largest provider of hair testing for drugs of abuse, is pleased to announce the appointment of Shannon...
Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2023 14:00 ET
|
Psychemedics Corporation
ACTON, Mass., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, announced the grant of inducement awards to...
Psychemedics Corporation Reports Second Quarter 2023 Financial Results
August 11, 2023 17:10 ET
|
Psychemedics Corporation
ACTON, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the...
Psychemedics Corporation Announces CEO Succession Plan
July 12, 2023 17:15 ET
|
Psychemedics Corporation
Brian Hullinger Will Succeed Ray Kubacki as CEO Effective August 17, 2023 Mr. Hullinger Brings 30 Years of Leadership Experience and a Proven Track Record of Driving Growth ACTON, Mass., July ...